Colliers International


Colliers International has been an active participant in the Life Science/Biotechology real estate markets since the early 1980s when the biotechnology industry started to take shape in Cambridge. We have a successful and proven track record of working with both tenants and landlords on life science transactions, and have many long-standing client relationships. To date, Colliers International has completed over 7 million square feet of biotech real estate assignments for our clients.
Whether your organization is a start-up biotech firm, a mature biotech or pharmaceutical company, or an institutional research organization, Colliers International has the resources, experience, and knowledge to help you develop and execute real estate strategies that foster and promote your organization’s plans and objectives. Start-ups, in particular, benefit greatly from our experience in assisting young companies to implement their growth strategies and build the team of specialists required to successfully complete a project.

The Boston office of Colliers International has been operating since 1875. With over 150 commercial real estate professionals and staff in the Boston office, we offer a comprehensive portfolio of real estate services to occupiers, owners and investors on a local, regional, national and international basis. The foundation of our long-term success is exceptional service, unparalleled market knowledge, business acumen and a deep dedication to our community.

Colliers International is a global leader in real estate services with more than 15,800 professionals operating out of 485 offices in 63 countries. The company is the third largest commercial real estate services firm in the world. Colliers offers the stability of a strong financial partner, providing clients with accountability and enterprising real estate solutions.

See all Members